EICHORCondition: Type 2 Diabetes · Sponsor: Intarcia Therapeutics
An 39-week plus extensions, open-label study to estimate the reduction in HbA1c in patients with initial HbA1c \>10% \</=12% who are treated with ITCA 650 20 mcg/day for 13 weeks followed by ITCA 650 60 mcg/day for 26 weeks plus optional 26-week extensions with continued treatment with ITCA 650 60 mcg/day
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Men or women age 18 to 80 years with type 2 diabetes * On stable treatment regimen of diet and exercise alone or in combination with a stable \& optimal or near-optimal dose of metformin, sulfonylurea, TZD or combination of these drugs * HbA1c \>10.0% and ≤12.0% Exclusion Criteria: * Prior treatment with any GLP-1 receptor agonist * History of hypersensitivity to exenatide or liraglutide * FPG \>300 mg/dL * History of medullary thyroid cancer or a family or personal history of multiple endocrine neoplasia type 2 * Taking DPP-4 inhibitors, incretin mimetics, alpha glucosidase inhibitors, meglitinides or insulin within last 3 months * history of pancreatitis
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Alabama Clinical Therapeutics, LLC | Birmingham, Alabama, United States | — |
| Fundamental Research | Gulf Shores, Alabama, United States | — |
| East Valley Family Physicians, PLC | Chandler, Arizona, United States | — |
| Desert Clinical Research | Mesa, Arizona, United States | — |
| Clinical Research Advantage, Inc. | Phoenix, Arizona, United States | — |
| eStudySite | Chula Vista, California, United States | — |
| Rocks Medical Research Institute, Inc. | Fresno, California, United States | — |
| Rocks Medical Research Institute | Fresno, California, United States | — |
| Long Beach Center for Clinical Research | Long Beach, California, United States | — |
| Saviers Medical Group | Port Hueneme, California, United States | — |
| University Clinical Investigatons, Inc/Diabetes Research Center | Tustin, California, United States | — |
| Diablo Clinical Research, Inc. | Walnut Creek, California, United States | — |
+ 39 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01785771